EU TRANSPARENCY REGISTER · 623930744946-01 · United States

Breakthrough T1D

Category

NGO / platform

Country

United States

New York

Entity form

Nonprofit organization

Stated objectives

Breakthrough T1D is the leading global organization funding type 1 diabetes research, with the goal to accelerate life-changing breakthroughs to cure, prevent and treat type 1 diabetes and its complications. To accomplish this, Breakthrough…

As declared by the registrant. Truncated to 240 characters; full text on the upstream profile.

Official profile

The full record on the Joint Transparency Register carries financial information (lobby budget, EU funding received), the list of named accredited representatives, declared interests of those persons, and a history of meetings with Commission officials.

Registered

2021-12-17

Last updated

2025-12-01

Other NGO / platform in United States

Other registered organisations in United States

Frequently asked questions

What is this organisation?
Breakthrough T1D is an interest representative listed in the EU Joint Transparency Register under ID 623930744946-01. Entity form: Nonprofit organization.
What category is it registered under?
It is registered under the category "Non-governmental organisations, platforms and networks and similar".
Which country is it based in?
The organisation is based in United States, New York.
What are its stated goals?
As declared by the registrant: Breakthrough T1D is the leading global organization funding type 1 diabetes research, with the goal to accelerate life-changing breakthroughs to cure, prevent and treat type 1 diabetes and its complications. To accomplish this, Breakthrough…
Where can I find its EU Transparency Register entry?
The full register entry — including lobby budget, EU funding received, accredited representatives and Commission meetings — is available on the EU Transparency Register under ID 623930744946-01.

Source: EU Joint Transparency Register (Council / Commission / Parliament) · refreshed 2026-07-02 · Commission Reuse Decision 2011/833/EU